Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid VP (VP.) by Steve Moore in ShareProphets
- Sector Perform Barratt Redrow (BTRW) by RBC Capital
- Avoid Genflow Biosciences (GENF) by Tom Winnifrith in ShareProphets
- Neutral BP (BP.) by Exane
- Buy Flutter Entertainment (DI) (FLTR) by Goldman Sachs
- Buy AstraZeneca (AZN) by Goldman Sachs
- Reduce BP (BP.) by HSBC
- Overweight Smurfit Westrock (DI) (SWR) by JP Morgan
- Overweight Unite Group (UTG) by JP Morgan
- Overweight Barclays (BARC) by JP Morgan
- Underperform HGCapital Trust (HGT) by Jefferies
- Hold Hollywood Bowl Group (BOWL) by Helen Cahill in The Times - Tempus
- Overweight NATWEST GROUP (NWG) by JP Morgan
- Avoid Altitude Group (ALT) by Steve Moore in ShareProphets
- Buy Thor Explorations Ltd (DI) (THX) by Hot Stock Rockets in ShareProphets
- Watch Sanderson Design Group (SDG) by Steve Moore in ShareProphets
- Buy AstraZeneca (AZN) by LBBW
- Avoid Aptitude Software Group (APTD) by Steve Moore in ShareProphets
- Neutral BP (BP.) by UBS
- Neutral Drax Group (DRX) by Citi
Renalytix (Reg S) (RENX) Share Price
Health Care Sector
NOTE: This is based on 14 open tips for Renalytix (Reg S) (RENX)
| Latest Bid : 4.00p | Latest Ask : 4.50p |
| High Today : 4.50p | Low Today : 4.00p |
| This Years High : 11.50p | This Years Low : 4.00p |
| Volume : 1,130,013 | MKT Cap : £7.65M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Renalytix (Reg S) (RENX) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.Renalytix (Reg S) (RENX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | 61.43% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -94.20% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.52% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.26% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.68% |
Renalytix (Reg S) (RENX) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 4.00p | Latest Ask : 4.50p |
| High Today : 4.50p | Low Today : 4.00p |
| This Years High : 11.50p | This Years Low : 4.00p |
| Volume : 1,130,013 | MKT Cap : £7.65M |
Renalytix (Reg S) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Renalytix (Reg S) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | 61.43% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -94.20% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.52% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.26% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.68% |